ZahraPakbazMD
Hematology • Orange, CASickle Cell & Other Anemias
Health Sciences Associate Clinical Professor
Dr. Pakbaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UC Irvine Medical Center
101 The City Dr South
Orange, CA 92868Phone+1 714-456-8000- Is this information wrong?
Summary
- Dr. Zahra Pakbaz is an adult hematologist and associate clinical professor at UC Irvine medical center in Orange and Laguna Hills , CA. She received her medical degree from Tehran University of Medical Sciences School of Medicine, completed her internal medicine residency at University of Maryland/ Union Memorial Hospital in Baltimore and hematology fellowship at NIH/NHLBI in Bethesda Maryland. She specializes in benign hematology which includes sickle cell anemia, thalassemia, Iron overload, aplastic anemia, PNH and other rare anemias, ITP.
Clinical Expertise
- Thalassemias, Aplastic anemia, Iron overload, Sickle cell anemia, Non cancer blood disorders
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2013
MedStar Health (Baltimore)Residency, Internal Medicine, 2008 - 2011
Tehran University of Medical Sciences School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2011 - 2025
MD State Medical License 2011 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment Start of enrollment: 2021 Jan 25
- Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer Start of enrollment: 2019 Sep 30
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises Start of enrollment: 2021 Oct 26
- Join now to see all
Publications & Presentations
PubMed
- Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.Jennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, Laurice Levine, Neelam Dongha, Nanxin Li, Farrukh Shah, Antony P Martin, Zahra Pakbaz> ;The Patient. 2024 Mar 26
- Caplacizumab as rescue therapy in refractory TTP involving neurologic features.Minh-Ha Tran, Lisa X Lee, Yen Cao, Lan Vu, Zahra Pakbaz> ;Transfusion and Apheresis Science. 2023 Jun 1
- 1 citationsHemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease.William B Ershler, Laura M De Castro, Zahra Pakbaz, Aaron Moynahan, Derek Weycker, Thomas E Delea, Irene Agodoa, Ze Cong> ;Current Therapeutic Research, Clinical and Experimental. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- Health-Related Quality of Life and Disease Impacts in Adults with Transfusion-Dependent β-Thalassemia: Preliminary Results from the Global Longitudinal SurveyLi N, Drahos J, Boateng-Kuffour A, Calvert M, Levine L, Dongha N, Pakbaz Z, , Oran F, Iqbal K, Shah F, Martin A, 64th ASH Annual Meeting and Exposition, Hall D Ernest Morial Convention Center New Orleans Luisiana, 12/12/2022
- A Pilot Adult Sickle Cell Hematology Clinic in CaliforniaÍs Inland Empire Improves Patient OutcomeZahra Pakbaz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
A New Treatment for Sickle Cell Anemia May Soon Be Available, What to KnowNovember 5th, 2023- Key FDA Panel Says New Gene-Editing Cure for Sickle Cell Anemia Is SafeNovember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
